Viral Hepatitis
Copyright ©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 14, 2006; 12(42): 6786-6791
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6786
Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C
Hitoshi Yoshiji, Ryuichi Noguchi, Hideyuki Kojima, Yasuhide Ikenaka, Mitsuteru Kitade, Kosuke Kaji, Masahito Uemura, Junichi Yamao, Masao Fujimoto, Masaharu Yamazaki, Masahisa Toyohara, Akira Mitoro, Hiroshi Fukui
Hitoshi Yoshiji, Ryuichi Noguchi, Hideyuki Kojima, Yasuhide Ikenaka, Mitsuteru Kitade, Kosuke Kaji, Masahito Uemura, Junichi Yamao, Masao Fujimoto, Masaharu Yamazaki, Masahisa Toyohara, Akira Mitoro, Hiroshi Fukui, Third Department of Internal Medicine, Nara Medical University, Nara, Japan
Author contributions: All authors contributed equally to the work.
Correspondence to: Hitoshi Yoshiji, MD, PhD, Third Department of Internal Medicine, Nara Medical University, Shijo-cho 840, Kashihara, Nara 634-8522, Japan. yoshijih@naramed-u.ac.jp
Telephone: +81-744-223051-2314 Fax: +81-744-247122
Received: July 18, 2006
Revised: September 15, 2006
Accepted: September 22, 2006
Published online: November 14, 2006
Core Tip